Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > MMP-1


Brief Information

Name:Matrix metalloproteinase-1
Target Synonym:Matrix Metallopeptidase 1 (Interstitial Collagenase),Matrix Metallopeptidase 1,Matrix Metalloproteinase-1,EC:,EC,CLG,Fibroblast Collagenase,Matrix Metalloproteinase 1 (Interstitial Collagenase),CLGN,MMP1,Matrix Metalloproteinase 1,MMP-1,EC 3.4.24,Interstitial Collagenase,Matrix Metalloprotease 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
MM1-H52H3 Human Human MMP-1 Protein, His Tag (active enzyme, MALS verified)
ACRO Quality

Part of Bioactivity data

MMP-1 MALS images

The purity of Human MMP-1 Protein, His Tag (Cat. No. MM1-H52H3) is more than 85% and the molecular weight of this protein is around 60-80 kDa verified by SEC-MALS.

Synonym Name



Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. Thrombospondins, intervertebral disc proteins, regulate the effective levels of matrix metalloproteinases (MMPs) 2 and 9, which are key effectors of ECM remodeling. Matrix metalloproteinase-1 (MMP-1) is also known as interstitial collagenase and fibroblast collagenase. MMP

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
BT-1718 BDC-17; BT-1718 Phase 2 Clinical Bicycle Therapeutics Solid tumours; Esophageal Neoplasms; Neoplasms; Sarcoma; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message